IN Brief:
- GEODIS will open a temperature-controlled pharmaceutical warehouse near Manchester Airport on 1 June 2026.
- The facility will provide 2,000 pallet positions across controlled room temperature and chilled environments.
- The site strengthens UK and Ireland healthcare logistics capability close to airfreight and motorway links.
GEODIS will open a new temperature-controlled, GDP-compliant pharmaceutical warehouse near Manchester Airport on 1 June 2026.
The facility has been designed to support inventory management and cross-docking operations for the UK and Ireland pharma and healthcare market. It will provide 2,000 pallet positions and handle sensitive pharmaceutical products that require strict temperature management and regulatory compliance.
The warehouse will include a controlled room temperature area maintained at 15°C to 25°C, chilled environments operating at 2°C to 8°C, dedicated returns areas, and continuous temperature monitoring backed by 24/7 alert systems. Frozen storage can also be introduced if required.
The site is located close to the M6 and M62 transport corridors and near Manchester Airport, giving it domestic distribution reach and international airfreight connectivity. The location places the facility within reach of northern England’s healthcare, biotech, and life sciences activity, while supporting national distribution across the UK and Ireland.
The investment adds regulated logistics capacity at a time when healthcare supply chains require tighter control over storage, returns, and product movement. Pharmaceutical distribution is increasingly shaped by biologics, vaccines, diagnostics, advanced therapies, and temperature-sensitive medicines that need validated handling environments throughout the journey.
Returns capability is an important part of the warehouse design. Healthcare reverse logistics requires more control than standard retail returns because products may need quarantine, inspection, temperature history review, and controlled disposition before they can be returned to stock or removed from the supply chain. Housing returns within the same controlled infrastructure can reduce handling complexity and improve documentation.
Manchester gives the facility a strong logistics position. Airport proximity supports international shipments and time-sensitive air cargo, while motorway access supports onward distribution into the North West, Midlands, Scotland, Wales, Ireland, and southern England. That combination gives pharma manufacturers and healthcare distributors a northern alternative to logistics networks that have often been weighted towards southern gateway locations.
The site also responds to the need for more resilient regional healthcare infrastructure. Concentrating too much specialist capacity in a small number of nodes can create vulnerability when transport links are disrupted, airport capacity tightens, or demand rises sharply. Regional controlled storage and cross-docking gives supply chains more options and shortens the distance between stock, airfreight, and healthcare demand centres.
GEODIS’ Manchester warehouse extends the company’s pharma and healthcare capability in a market where compliance and operational reliability are now inseparable. Temperature control, monitoring, returns management, and proximity to transport infrastructure are becoming core elements of pharmaceutical supply chain design, rather than value-added services around the edge of conventional warehousing.
